TrialJPEN. Journal of parenteral and enteral nutrition2022

Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome: An open-label phase 1 and 2 metabolic balance trial.

Johanna Eliasson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.